Novel Antiatherosclerotic Therapies

Arteriosclerosis, thrombosis, and vascular biology

Volumn 39, Issue 4, 2019, Pages 538-545

  Libby, Peter ^a   Everett, Brendan M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

atherosclerosis; colchicine; cytokines; interleukin 1; lipids; methotrexate; thrombosis

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CANAKINUMAB; MONOCLONAL ANTIBODY;

ATHEROSCLEROSIS; CELL CLONE; CLINICAL TRIAL (TOPIC); EXPERIMENTAL THERAPY; HEMATOPOIESIS; HUMAN; INFLAMMATION; LIFESTYLE; MOLECULARLY TARGETED THERAPY; PROCEDURES; RISK FACTOR; VACCINATION;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIOXIDANTS; ATHEROSCLEROSIS; CLINICAL TRIALS AS TOPIC; CLONE CELLS; HEMATOPOIESIS; HUMANS; INFLAMMATION; LIFE STYLE; MOLECULAR TARGETED THERAPY; RISK FACTORS; THERAPIES, INVESTIGATIONAL; VACCINATION;

EID: 85063969631     PISSN: None     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.118.310958     Document Type: Review

References (0)